Clinical Profile and Outcomes of Acute Myeloid Leukemia: An Institutional Experience from South India
Journal Title: Indian Journal of Cancer Education and Research - Year 2019, Vol 7, Issue 2
Abstract
Background: Acute myeloid leukemia is a heterogenous clonal disorder of hematopoietic progenitor cells with different molecular genetic abnormalities, clinical characteristics and variable outcomes with currently available treatment. Aim of the study is to analyse the clinical profile & outcomes of AML, an institutional experience where BMT facility is not available. Aims: Clinical profile and outcomes of Acute myeloid leukemia is evaluated. Material and Methods: Retrospective chart review of 51 patients diagnosed of AML with clinical and therapeutic data analysed. Results: 51 patients were analysed (males 30, females 21) with a male predominance. 90% (46/51) of patients were in the age group of <60 yrs & nearly 40% (20/51) were 15–30 yrs which is significant. M2 was the most common FAB subtype with 23/51 (45%) cases and most common presentation is fever. The observed average baseline parameters were: Hb of 6–8 gr% with 30% showed <6 gr%,TLC >15,000 in 90% of cases which confer poor outcomes (60% cases – >50,000 and 30% – >1 lakh). The average platelet count was 20,000–40,000 (25% cases – <20,000). Most patients had a baseline blasts% of >70. The average number of transfusions required during induction were in the range of (PRBCs-4–6, RDPs-20–30, SDPs-2–4 & overall 25–35). Among 51 patients, approxly 75% (38/51) were treated with intensive chemotherapy and 13 were on BSC. Remission rate was found to be 42% (16/38) in patients who received induction chemotherapy while >95% of them relapsed. As most of the patients were not on follow up or died, no follow up data was found to calculate the survivals. Conclusions: AML is an aggressive malignancy with poor outcomes and high relapse rates, especially without BMT. Supportive care constitutes a major component of management. As most of the patients were presenting very late and in poor PS (bad parameters at baseline) early aggressive treatment with strong supportive care improve the cure rates and survival.
Authors and Affiliations
Venkatesh Mushini
Keywords
Related Articles
- EP ID EP668617
- DOI 10.21088/ijcer.2321.9815.7219.7
- Views 112
- Downloads 0
Exploring the Automotive Analogy of Neoplastic Progression: How Do Cancer Cells 'Gear Up' to Evade & Invade?
Cancer is a multifactorial and multistep disorder driven by acquired mutations/defects in components that contribute to coordinating replication, behaviour and fate in the individual cells of multicellular body organi...
Epidemiology and Molecular Classification Status in Cancer Breast in Central India: An Institutional Study
Aim: Breast cancer is the most common cancer among women worldwide and also in India. Patients with same diagnosis have different clinical outcomes and prognosis. This study aimed to evaluate molecular classification in...
Induction Chemotherapy in Unresectable or Locally Advanced Head and Neck Squamous Cell Cancer: A Single Center Retrospective Experience
Head and Neck Squamous Cell Carcinoma (HNSCC), have an unsatisfactory prognosis despite intensive local treatment. Single institution retrospective study of 60 patients, who were treated with induction chemotherapy follo...
A Study on Prevalence of HPV Infection in Head and Neck Cancer
Introduction: The HPV prevalence in India ranges from 33.6% in the Eastern region to 67% in South India and 15% in Western India. The prevalence of HPV6, HPV11, HPV16, and HPV18 were 13%, 20%, 42%, and 47%, respectively....
Role of Image Guided Radiotherapy (IGRT) in Patients Treated with Intensity Modulated Radiotherapy (IMRT) & Volumetric Modulated Arc Therapy (VMAT) in Head and Neck and Pelvic Cancers
Background: IGRT is the latest development for increasing the precision and accuracy in radiation therapy. Usage of specialized multi professional teams for coordinating geometric verification and use of clearly defined...